[(3R,4R)-4-[[(3aS,6aR)-2-[2-chloro-4-[[5-[1-(2,2-difluorocyclopropyl)-3-(trifluoromethyl)pyrazol-4-yl]-1-methylimidazole-2-carbonyl]amino]benzoyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carbonyl]amino]pyrrolidin-3-yl] formate
C31H31ClF5N9O5 — CID 155098726
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(3R,4R)-4-[[(3aS,6aR)-2-[2-chloro-4-[[5-[1-(2,2-difluorocyclopropyl)-3-(trifluoromethyl)pyrazol-4-yl]-1-methylimidazole-2-carbonyl]amino]benzoyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carbonyl]amino]pyrrolidin-3-yl] formate
[(3R,4R)-4-[[(3aS,6aR)-2-[2-chloro-4-[[5-[1-(2,2-difluorocyclopropyl)-3-(trifluoromethyl)pyrazol-4-yl]-1-methylimidazole-2-carbonyl]amino]benzoyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carbonyl]amino]pyrrolidin-3-yl] formate (PubChem CID 155098726) has the molecular formula C31H31ClF5N9O5 and a molecular weight of 740.09 g/mol. Its IUPAC name is [(3R,4R)-4-[[(3aS,6aR)-2-[2-chloro-4-[[5-[1-(2,2-difluorocyclopropyl)-3-(trifluoromethyl)pyrazol-4-yl]-1-methylimidazole-2-carbonyl]amino]benzoyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carbonyl]amino]pyrrolidin-3-yl] formate.
Molecular Properties
| Compound Name | [(3R,4R)-4-[[(3aS,6aR)-2-[2-chloro-4-[[5-[1-(2,2-difluorocyclopropyl)-3-(trifluoromethyl)pyrazol-4-yl]-1-methylimidazole-2-carbonyl]amino]benzoyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carbonyl]amino]pyrrolidin-3-yl] formate |
|---|---|
| PubChem CID | 155098726 |
| Molecular Formula | C31H31ClF5N9O5 |
| Molecular Weight | 740.09 g/mol |
| Exact Mass | 739.21 |
| IUPAC Name | [(3R,4R)-4-[[(3aS,6aR)-2-[2-chloro-4-[[5-[1-(2,2-difluorocyclopropyl)-3-(trifluoromethyl)pyrazol-4-yl]-1-methylimidazole-2-carbonyl]amino]benzoyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carbonyl]amino]pyrrolidin-3-yl] formate |
| SMILES | Cn1c(-c2cn(C3CC3(F)F)nc2C(F)(F)F)cnc1C(=O)Nc1ccc(C(=O)N2C[C@H]3CN(C(=O)N[C@@H]4CNC[C@H]4OC=O)C[C@H]3C2)c(Cl)c1 |
| InChI | InChI=1S/C31H31ClF5N9O5/c1-43-22(19-13-46(24-5-30(24,33)34)42-25(19)31(35,36)37)7-39-26(43)27(48)40-17-2-3-18(20(32)4-17)28(49)44-9-15-11-45(12-16(15)10-44)29(50)41-21-6-38-8-23(21)51-14-47/h2-4,7,13-16,21,23-24,38H,5-6,8-12H2,1H3,(H,40,48)(H,41,50)/t15-,16+,21-,23-,24?/m1/s1 |
| InChIKey | VXBKALZOIVLDQN-PRJCYHQBSA-N |
| XLogP | 3.02 |
| TPSA | 155.72 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 51 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 740.09 |
| LogP ≤ 5 | 3.02 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 10 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155098726 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.